Please use this identifier to cite or link to this item:
http://acervodigital.unesp.br/handle/11449/74547
- Title:
- Mathematical analysis and simulations involving chemotherapy and surgery on large human tumours under a suitable cell-kill functional response
- Universidade de São Paulo (USP)
- Universidade Estadual Paulista (UNESP)
- 1547-1063
- 1551-0018
- Dosage and frequency of treatment schedules are important for successful chemotherapy. However, in this work we argue that cell-kill response and tumoral growth should not be seen as separate and therefore are essential in a mathematical cancer model. This paper presents a mathematical model for sequencing of cancer chemotherapy and surgery. Our purpose is to investigate treatments for large human tumours considering a suitable cell-kill dynamics. We use some biological and pharmacological data in a numerical approach, where drug administration occurs in cycles (periodic infusion) and surgery is performed instantaneously. Moreover, we also present an analysis of stability for a chemotherapeutic model with continuous drug administration. According to Norton & Simon [22], our results indicate that chemotherapy is less eficient in treating tumours that have reached a plateau level of growing and that a combination with surgical treatment can provide better outcomes.
- 1-Feb-2013
- Mathematical Biosciences and Engineering, v. 10, n. 1, p. 221-234, 2013.
- 221-234
- Chemotherapy
- Mathematical modelling
- Norton-Simon hypothesis
- Tumour
- antineoplastic agent
- algorithm
- biological model
- conference paper
- drug therapy
- human
- kinetics
- methodology
- neoplasm
- oncology
- pathology
- statistical model
- Algorithms
- Antineoplastic Agents
- Drug Therapy
- Humans
- Kinetics
- Medical Oncology
- Models, Biological
- Models, Statistical
- Neoplasms
- http://dx.doi.org/10.3934/mbe.2013.10.221
- Acesso restrito
- outro
- http://repositorio.unesp.br/handle/11449/74547
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.